• Home
  • About
  • Listings by Category
    • Educational Programs in Computational Biology
      • Undergraduate Computational Biology/Bioinformatics Programs
      • Undergraduate Biostatistics Programs
      • Graduate Computational Biology/Bioinformatics Programs
    • Summer Programs for Undergrads
    • Employers
      • Agriculture
      • Automation
      • Cancer Research
      • Contract Research
      • Diagnostics
      • Drug Discovery
      • Genetic Testing
      • Genomics
      • Graduate Biostatistics Programs
      • Healthcare Services
      • Human Longevity
      • Medical Devices
      • Medical Imaging
      • Other
      • Pharmaceuticals
      • Research Institutes
      • Software Development
      • Synthetic Biology
  • Job Board
  • Our Department
Main Menu
  • Home
  • About
  • Listings by Category
    • Educational Programs in Computational Biology
      • Undergraduate Computational Biology/Bioinformatics Programs
      • Undergraduate Biostatistics Programs
      • Graduate Computational Biology/Bioinformatics Programs
    • Summer Programs for Undergrads
    • Employers
      • Agriculture
      • Automation
      • Cancer Research
      • Contract Research
      • Diagnostics
      • Drug Discovery
      • Genetic Testing
      • Genomics
      • Graduate Biostatistics Programs
      • Healthcare Services
      • Human Longevity
      • Medical Devices
      • Medical Imaging
      • Other
      • Pharmaceuticals
      • Research Institutes
      • Software Development
      • Synthetic Biology
  • Job Board
  • Our Department

Ardelyx

34175 Ardenwood Boulevard
Fremont, CA 94555
Pharmaceuticals
34175 Ardenwood Boulevard
Fremont, CA 94555
www.ardelyx.com

Description

Ardelyx is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative, minimally-systemic, small molecule therapeutics that work exclusively in the gastrointestinal (GI) tract to treat GI and cardio-renal diseases.

Ardelyx has developed a proprietary drug discovery and design platform enabling it, in a rapid and cost-efficient manner, to discover and design novel drug candidates. Utilizing this platform, Ardelyx has discovered and designed tenapanor, which it is evaluating for the treatment of irritable bowel syndrome with constipation (IBS-C) and for the treatment of hyperphosphatemia in patients with end-stage renal disease (ESRD) on dialysis. In addition to tenapanor, Ardelyx is developing RDX227675, a non-absorbed polymer for the treatment of hyperkalemia, or high potassium, a problem prevalent in patients with kidney and heart disease. Ardelyx is also advancing several research programs focused in GI and cardio-renal diseases.

Source: https://www.linkedin.com/company/ardelyx-inc-/

Company Size: 51-200 employees

Connect

  • Twitter URL
  • LinkedIn URL

Contact Us

CMU Computational Biology Department
5000 Forbes Ave
Pittsburgh, PA 15213
(412) 268-4671
social@cbd.cmu.edu

Legal Info

Follow our Twitter list of companies!

My Tweets

Computational Biology Career Events

No upcoming events

Copyright © 2018 Carnegie Mellon University. All Rights Reserved

Login

Lost your password?